Antibiotics Delivery for Treating Bone Infections

Osteomyelitis is an infection of bone and bone marrow. It is attributed to several factors: antibiotic short half-life, poor blood circulation at the infected area, and systemic antibiotic toxicity usage of the required high systemic dose. All evocating osteomyelitis presents an additional challenge, because the infecting bacteria form a biofilm mode of growth, which, on devascularized surfaces, shields them from antibiotics. Widespread research is currently being conducted on local drug delivery systems to treat osteomyelitis. By utilizing newer forms of sustained-release antibiotic delivery systems, it will be possible to deliver such antibiotics at constant rates over a prolonged period of time and eliminate the need for multiple dosing.